Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aarti Drugs Limited Call Transcript 2022

Oct 18, 2022

62194_rns_2022-10-18_78e07ede-f833-4d97-8621-6071f083707c.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [512 x 106] intentionally omitted <==

Ref: ADL/SE/2022-23/62 October 17, 2022

To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348

Dear Sir/Madam,

Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Friday, October 21, 2022 at 12:00 Noon IST to discuss the Company’s financial performance for the Quarter and half year ended September 30, 2022. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

RUSHIKESH VIVEK DEOLE Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, o=PERSONAL, title=5599, pseudonym=52288d43536c4230831c2e75cd4b8c59, 2.5.4.20=073813c4edff683f8b6ec3cb4e69ca6d8d4f7258a44f635abc18581eaa522821, postalCode=421301, st=Maharashtra, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b575f6fc0484483273dabfc17f, cn=RUSHIKESH VIVEK DEOLE Date: 2022.10.17 20:02:33 +05'30'

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 29] intentionally omitted <==

==> picture [117 x 54] intentionally omitted <==

Aarti Drugs Limited

Cordially invites you to

Conference Call

To discuss the financial performance for the Quarter and Half-year ended 30[th] September, 2022

Day/Date : Friday, 21[st] October, 2022 Time : 12:00 Noon, IST

Diamond Pass : Please Click here to express join the Call

+91 22 6280 1309 Primary Number: +91 22 7115 8210 – Hongkong 800964448 – Singapore 8001012045 Toll Free Number: UK – 08081011573 – US 18667462133

Participants:

Mr. Harshit Savla – Jt. Managing Director Mr. Harit Shah – Whole time Director

Mr. Adhish Patil – Chief Finance Officer

Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited

We look forward to your participation

RSVP

Jigar Kavaiya / Chinmay Madgulkar, Strategic Growth Advisors Pvt. Ltd., Contact: +91 99206 02034/ 98600 88296